Skip to main content
Caplight Logo









INCATE

INCATE

Basel, Basel-Stadtincate.net

Overview

A not-for-profit partnership that serves as an incubator for early-stage innovators and start-ups fighting antimicrobial resistance (AMR). It brings together academia, industry, entrepreneurs, and investors to provide support through expert advice, community building, and non-dilutive funding to accelerate the development of new therapies and diagnostics.

Portfolio Companies

17

Website

incate.net

Investments

INCATE investments
CompanyDateStageLead
Paralos BioscienceAug 2026SeedCo-investor
i-Seq BiotechnologyJun 2026GrantCo-investor
AstralytixMay 2026AcceleratorCo-investor
Brigid Bio LtdSep 2025Pre SeedCo-investor
AlterbiotixSep 2025Convertible DebtCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBasel, Basel-Stadt
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?